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ORIGINAL ARTICLE
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ABSTRACT
The translocation of transcription factor EB (TFEB) to the nucleus plays a pivotal role in the regu-
lation of basic cellular processes, such as lysosome biogenesis and autophagy. Autophagy is an
intracellular degradation system that delivers cytoplasmic constituents to the lysosome, which is
important in maintaining cellular homeostasis during environmental stress. Furthermore, oxida-
tive stress is a critical cause for the progression of neurodegenerative diseases. Curcumin has
anti-oxidative and anti-inflammatory activities, and is expected to have potential therapeutic
effects in various diseases. In this study, we demonstrated that curcumin regulated TFEB export
signalling via inhibition of glycogen synthase kinase-3b (GSK-3b); GSK-3b was inactivated by cur-
cumin, leading to reduced phosphorylation of TFEB. We further showed that H2O2-induced oxi-
dative stress was reduced by curcumin via the Nrf2/HO-1 pathway in human neuroblastoma
cells. In addition, we showed that curcumin induced the degradation of amyloidogenic proteins,
including amyloid-b precursor protein and a-synuclein, through the TFEB-autophagy/lysosomal
pathway. In conclusion, curcumin regulates autophagy by controlling TFEB through the inhibition
of GSK-3b, and increases antioxidant gene expression in human neuroblastoma cells. These
results contribute to the development of novel cellular therapies for neurodegenerative diseases.
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Autophagy plays an important role in cellular homeo-
stasis through the elimination of old or damaged
organelles, as well as aggregated intracellular proteins
[1,2]. It is associated with a variety of biological func-
tions, such as development, cellular differentiation,
defense against pathogens, and nutritional starvation.
Defects in autophagic regulation play a central role in a
number of diseases, including neurodegenerative dis-
eases, cancer, pathogen infection, and metabolic dis-
eases [3]. In addition, autophagy has been reported to
be involved in the occurrence of pathological changes
in many neurodegenerative disorders, including
Alzheimer’s disease (AD) and Parkinson’s disease (PD)
[4]. The most prevalent pathological features of many
neurodegenerative diseases are the aggregation of mis-
folded proteins and the loss of certain neuronal
populations [5]. Moreover, oxidative stress is a major
factor in neurodegenerative disorders [6–8]. The induc-
tion of antioxidant enzymes, such as haem oxygenase-1
(HO-1), prevents a key early pathogenic process in
AD [9].
Numerous studies have shown that curcumin has
broad biological functions, including antioxidant and
anti-inflammatory activities [10–12]. Curcumin exerts
antioxidant activity in direct and indirect ways by scav-
enging reactive oxygen species (ROS) and inducing an
antioxidant response, respectively [13,14]. Moreover,
curcumin is known to promote transcription factor EB
(TFEB) nuclear translocation [15]. TFEB, a master gene
for lysosomal biogenesis, coordinates this programme
by driving the expression of autophagy and lysosomal
genes [16]. TFEB recognises and binds to a regulatory
sequence, the coordinated lysosomal expression and
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regulation (CLEAR) motif, which is present in the pro-
moter region of several autophagy-related genes [17].
This TFEB activity depends on its phosphorylation sta-
tus, which is mainly regulated by the mechanistic target
of rapamycin complex 1 (mTORC1), calcineurin, which is
a Ca2þ-dependent phosphatase, and mTOR-independ-
ent glycogen synthase kinase-3b (GSK-3b) [18,19].
GSK-3b is a serine/threonine kinase that is inhibited
by a phosphorylated Ser9 residue, and its phosphoryl-
ation or dephosphorylation serves an important switch
that regulates GSK-3b activity [20,21]. The binding of
GSK-3b by curcumin potently inhibits its activity, and
induces TFEB nuclear translocation by inhibiting TFEB
phosphorylation [21,22]. Phosphorylated TFEB is
retained in the cytoplasm, whereas dephosphorylated
TFEB translocates to the nucleus to induce the tran-
scription of target genes associated with autophagy
[18]. The subcellular distribution of TFEB mainly
depends on its phosphorylation status. A recent study
has reported that phosphorylated TFEB by GSK-3b, at
the serine 134 and 138 residues, can inhibit TFEB
nuclear translocation. Phosphorylation of S134 and
S138 appear to be critical for TFEB localisation to the
surface of lysosome, where it interacts with mTORC1.
Double mutations of S134A and S138A TFEB decreased
lysosomal localisation, and leading to its nuclear local-
isation [23]. According to numerous reports, genetic or
pharmacological activation of TFEB was shown to be
beneficial in a variety of neurodegenerative diseases
[24–26]. In neurodegenerative diseases, amyloidogenic
proteins, such as amyloid-b (Ab) precursor proteins or
a-synuclein (a-syn), have an increased tendency to
aggregate [27,28]. The hallmarks of AD are extracellular
senile plaques of aggregated Ab proteins, intracellular
neurofibrillary tangles, and synaptic and neuronal loss
[29–31]. In addition to the typical pathological changes
of AD, oxidative stress is also reported to be an import-
ant pathological phenomenon that starts to manifest
early in the course of AD [32–34]. Furthermore, accumu-
lative evidence has shown that the aggregation of
a-syn in neuronal cells is associated with PD [35,36]. It
is well demonstrated that GSK-3b dysregulation can
promote the pathology of neurodegenerative diseases
such as PD [37]. Additionally, curcumin has been identi-
fied as a potential neuroprotective agent in PD [38].
The underlying mechanism of curcumin involved in
the regulation of TFEB translocation in human neuro-
blastoma cells is largely unknown. Here, we hypothes-
ised that the suppression of GSK-3b by curcumin could
promote the TFEB-autophagy/lysosomal pathway, and
protect cells from the deposition of aggregated
proteins and H2O2-induced oxidative stress in human
neuroblastoma cells.
Materials and methods
Cell culture and chemical treatment
A human neuroblastoma cell line (SH-SY5Y) was grown
in Dulbecco’s Modified Eagle medium, DMEM (Gibco,
Grand Island, USA), supplemented with 4.5 g/L D-glu-
cose, L-Glutamine, 110mg/L Sodium pyruvate, 10% foe-
tal bovine serum (Gibco, Melbourne, Australia) and 1%
penicillin-streptomycin solution (Gibco, Grand Island,
USA). The cells were maintained at 37 C in a saturated
humidity atmosphere containing 95% air and 5% CO2.
SH-SY5Y cells were treated with 2.5, 5, 10, and 20mM
curcumin (Sigma Aldrich, St. Louis, MO, USA) for 12 and
24 h, respectively.
Immunofluorescence assay
SH-SY5Y cells inoculated on coverslips were cultured
for 24 h. Then, cells were fixed with 4% paraformalde-
hyde for 15min, and permeabilized with 0.1% Triton
X 100 for 5min. Following blocking with 3% BSA in
phosphate-buffered saline (PBS) for 30min, cells were
incubated with primary antibody: anti-a-syn (cell signal-
ling, MA, USA, 1:500 dilution) and anti-amyloid-b pre-
cursor protein (Sigma, MO, USA, 1:500 dilution);
overnight at 4 C. After primary antibody incubation,
cells were washed with PBS and incubated with Alexa-
Fluor 594 goat anti-rabbit secondary antibody
(Invitrogen, CA, USA, 1:500 dilution) for 1 h at room
temperature, stained with DAPI (1 mg/mL) for 15min
and washed with PBS. Images were captured using an
Olympus FV1200 confocal microscope (Olympus,
Tokyo, Japan).
Nuclear/cytosol fraction
Cells were harvested via mechanical scraping and split
into nuclear and cytoplasmic fractions utilising a
nuclear/cytosol fractionation kit (BioVision, CA, USA),
according to the manufacturer’s protocol.
Cell viability assay
WST-8 (QuantiMaxTM-cell viability assay kit) was used to
analyse cell viability according to the manufacturer’s
instructions. SH-SY5Y cells (1 105/well) were cultured
in 96-well plates, with triplicate wells for each group.
When 80–90% confluence was reached, cells were
treated with curcumin (2.5, 5, 10, 20, 40 and 80mM) at
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different concentrations in 100 ml DMEM medium and
incubated for 2 h. Then QuantiMaxTM solution was
added to each well followed by a further 4 h incubation
under 5% CO2 at 37 C. Absorbance was measured at
450 nm with a microplate reader (SpectraMax iD3,
TECAN Group Ltd.). The mean optical density (OD,
absorbance) of three wells in the indicated groups was
used to calculate the percentage of cell viability.
Transfection
SH-SY5Ycells were transfected with pEGFP-N1-TFEB
using LipofectamineTM 2000 (Invitrogen, CA, USA) in
accordance with the manufacturer’s protocol. To knock
down the GSK-3b gene, SH-SY5Y cells were transfected
with scramble siRNA (scRNA) and human GSK-3b siRNA
(Santa Cruz, TX, USA) using LipofectamineTM 2000
(Invitrogen, CA, USA). To assess the role of GSK-3b in
TFEB nuclear translocation, SH-SY5Y cells were trans-
fected with pcDNA3.1, constitutively active GSK3b
(pcDNA3.1-GSK3b-S9A, CA), and kinase-dead GSK3b
(pcDNA3.1-GSK3b-K85A, KD). To measure the effect of
curcumin on the amyloid-b precursor protein (APP) and
a-synuclein aggregation, SH-SY5Y cells were transfected
with pCAX-APP695-WT (FL-APP WT), pCAX-APP-Swe/Ind
(APP-Swe/Ind), p3x-flag-human a-synuclein-WT (a-syn
WT), and p3x-flag-human a-synuclein-A53T (a-syn
A53T) for 48 h and then processed for immunofluores-
cence microscopy. All plasmids were purchased from
Addgene (MA, USA).
Western blot
Total proteins extracted from harvested cells were pre-
pared in Mammalian Cell-PE LBTM Buffer (GBiosciences,
MO, USA) containing phosphatase inhibitors (SIGMA-
aldrich, MO, USA), and protease inhibitors (SIGMA-
Aldrich, MO, USA). Protein concentration was determined
using a BCA protein assay kit (Pierce Biotechnology, IL,
USA). For western blot analysis, protein samples were
separated using SDS-PAGE and transferred onto polyvi-
nylidene difluoride membranes (Millipore, MA, USA). The
membrane was blocked with 5% skim milk (BD DifcoTM
Skim Milk, PA, USA) in PBS-Tween 20 and then incubated
with a primary antibody against either TFEB (Cell signal-
ling, MA, USA, 1:1000 dilution), GSK-3b (Cell signalling,
MA, USA, 1:1000 dilution), p-GSK3b (Cell signalling, MA,
USA, 1:1000 dilution), p-b-catenin (Cell signalling, MA,
USA, 1:1000 dilution), b-catenin (Cell signalling, MA, USA,
1:1000 dilution), PARP1 (Cell signalling, MA, USA, 1:2000
dilution), a-tubulin (Cell signalling, MA, USA, 1:2000 dilu-
tion), LAMP1 (Abcam, MA, USA, 1:2000 dilution), LC3
(Novus Biologicals, CO, USA, 1:1000 dilution), FL-APP
(Sigma Aldrich, MO, USA, 1:1000 dilution), a-synuclein
(Cell signalling, MA, USA, 1:1000 dilution), or b-actin
(Invitrogen, CA, USA, 1:2500 dilution) followed by
incubation with a secondary antibody (Jackson
ImmunoResearch Laboratories, PA, USA, 1:5000 dilution).
All experiments were performed at least three times, and
representative results are shown. Chemiluminescent sig-
nal was measured with an Azure Biosystems C300 ana-
lyser (Azure Biosystems, Dublin, CA) using an ECL
detection system (GE Healthcare Bio-Sciences, Little
Chalfont, UK). The band density was analysed by using
Image J2x software (US National Institutes of Health,
Bethesda, MD).
Real-time quantitative-PCR (qRT-PCR)
Total RNA was extracted from cellular lysates using
Trizol (Life Technologies, CA, USA) according to the
manufacturer’s instructions. cDNA was synthesised by
using oligo (dT) primers (Bioneer, Daejeon, Korea) and
M-MLV reverse transcriptase (Promega, WI, USA) accord-
ing to the manufacturer’s protocol. The cDNA product
was amplified using SYBR Green PCR Master Mix
(Applied Biosystems, CA, USA) on an ABI 7500 Fast
Real-Time PCR System (Applied Biosystems, CA, USA).
mRNA expression data were normalised to GAPDH
gene expression. The forward and reverse primers for
human MCOLN1 were 50- GAGTGGGTGCGACAAGTTTC-
30 (forward) and 50-TGTTCTCTTCCCGGAATGTC-30
(reverse), and for human LAMP1 were 50-CGTACCTTTCC
AACAGCAGC-30 (forward) and 50-CGCTCACGTTGTACTT
GTCC-30(reverse), and for human GAPDH were 50-CAA
TGACCCCTTCATCCTC-30 (forward) and 50-AGCATCGCC
CCACTTGATT 30 (reverse).
Autophagy flux assay using tandem fluorescent-
tagged LC3
SH-SY5Y cells were transfected with pBABE-puro-
mCherry-EGFP-LC3B (Addgene, Cambridge, MA, USA,
#22418). After incubation with curcumin or other treat-
ments, the cells were fixed with 4% parpformadehyde
and then observed under Olympus FV1200 confocal
microscope (Olympus, Tokyo, Japan).
Luciferase assay
For the dual luciferase assay, SH-SY5Y cells were grown
in a 96-well plate and co-transduced with a pCignal
Lenti-ARE reporter (Qiagen, Hilden, Germany) and
pCignal Lenti-TK-Renilla (Qiagen, Hilden, Germany).
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After 72 h, cells were pre-treated with 20 mM curcumin
and 10mM LiCl for 30min followed by the administra-
tion of H2O2 (200 mM) for 6 h. Then, treated cells were
lysed with passive lysis buffer (Promega, Fitchburg, WI,
USA) and mixed with luciferase assay reagents
(Promega). The chemiluminescent signal was detected
using a SpectraMax L Microplate reader (Molecular
Devices, Sunnyvale, CA). Firefly luciferase was normal-
ised to Renilla luciferase in each sample.
ROS measurement
To measure intracellular ROS by flow cytometry, SH-
SY5Y cells were first transfected with scRNA and siRNA
against GSK-3b for 36 h. Then cells were pre-treated
with curcumin (20mM) and LiCl (10mM) for 3 h followed
by the stimulation of 200mM H2O2 for 6 h. Then cells
were placed in fluorescence-activated cell sorting tubes,
and washed with 1xPBS. Cells were incubated in 1xPBS
containing 3 mM CM-H2DCFDA (C6827, Invitrogen, CA)
for 40min at 37 C. DCF-DA fluorescence was detected
using a fluorescence-activated cell sorter (FACSCanto II)
and data was analysed with FlowJo V10 software (Tree
Star Inc., San Carlos, CA). The fold of change is pre-
sented by mean fluorescence intensity.
Statistical analysis
For statistical comparisons, all values were expressed as
mean± SD. Statistical differences between samples
were assessed by ANOVA with post hoc Turkey’s hon-
estly significant difference (HSD) test. Data were ana-
lysed and presented using GraphPad Prism software
version 5.03 (San Diego, CA). Probability values of
p 0.05 were considered to represent a statistically sig-
nificant change.
Results
Curcumin promotes TFEB nuclear translocation
through the inhibition of GSK-3b activity in SH-
SY5Y cells
A cell viability assay was initially employed to investi-
gate any potential cytotoxic effects of curcumin in the
neuroblastoma cell line (SH-SY5Y cells); the results
showed that treatment with various concentrations of
curcumin had no significant impact on cell viability
(Supplementary Figure S1(A)). Then, to determine the
effect of curcumin on GSK-3b activity, we examined
GSK-3b phosphorylated at S9 (p-GSK-3b (S9)), which is
considered an inactive form of GSK-3b, under different
concentrations of curcumin (0, 2.5, 5, 10, and 20mM).
Here, we treated cells with LiCl, a GSK-3b inhibitor, to
stimulate p-GSK-3b (S9), as a positive control to assess
the effect of curcumin on GSK-3b activity.
Immunoblotting results clearly supported that curcumin
enhanced p-GSK-3b (S9) in a dose-dependent manner
(Figure 1(A)). To further assess the inhibitory effect of
curcumin on the activity of GSK-3b, we measured the
levels of phosphorylation of a well-characterized sub-
strate of GSK-3b, b-catenin. Our results showed that the
administration of curcumin dramatically decreased the
phosphorylation of b-catenin due to the inactivation of
GSK-3b (Figure 1(A)). A previous study has shown that a
novel curcumin analog can induce the translocation of
TFEB from the cytosol to the nucleus [39]. Next, to
examine the role of curcumin in TFEB nuclear transloca-
tion in a human neuroblastoma cell line, we transfected
SH-SY5Y cells with GFP-tagged TFEB for 48 h, and
observed that the curcumin treatment could dramatic-
ally increase the nuclear translocation of TFEB (Figure
1(B,C)). Torin1, an mTOR inhibitor, (Figure 1(B)) or LiCl
(Supplementary Figure S1(B)) was used as positive con-
trols. A previous study showed that cells transfected
with siRNA against GSK-3b (siGSK-3b) and pharmaco-
logical inhibition of GSK-3b could both promote TFEB
nuclear translocation and subsequently elevate the
autophagy-lysosomal pathway [40]. To evaluate the crit-
ical role of GSK-3b in TFEB nuclear translocation fol-
lowed by curcumin treatment, we transfected SH-SY5Y
neuroblastoma cells with two kinds of mutant forms of
GSK-3b, GSK-3b CA and GSK-3b KD. We first isolated the
nuclear and cytoplasmic fraction, and examined the
relative expression of TFEB in these fractions. As we
expected, curcumin treatment could significantly
increase the nuclear translocation in cells transfected
with pcDNA, while GSK-3b CA transfection compro-
mised the beneficial effect of curcumin on TFEB nuclear
translocation. Interestingly, the nuclear fraction isolated
from cells transfected with GSK-3b KD showed a
remarkable increase of TFEB expression in the presence
or absence of curcumin treatment (Figure 1(D)). SH-
SY5Y cells were treated with Torin1 (Figure 1(D)) and
LiCl (Supplementary Figure S1(C)) as positive controls.
These results clearly demonstrated that curcumin could
promote TFEB nuclear translocation via the phosphoryl-
ation of GSK-3b at the serine 9 residue in SH-SY5Y cells.
Inhibition of GSK-3b by curcumin facilitates
autophagy progression
Our results demonstrated that curcumin could promote
TFEB nuclear localisation, which was found to be associ-
ated with the inactivation of GSK-3b (Figure 1). TFEB
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nuclear translocation plays a fundamental role in the
progression of autophagy by upregulating master
genes involved in lysosomal biogenesis [16]. Therefore,
we next investigated whether curcumin could induce
autophagy through the inactivation of GSK-3b. We first
examined autophagy- related genes, including lyso-
somal-associated membrane protein 1 (LAMP-1), which
is one of the target genes of TFEB, and lipid bound
LC3-II, in various concentrations of curcumin. As shown
in Figure 2(A), we found that curcumin treatment could
significantly increase the protein levels of LAMP1 and
LC3-II, and decrease the levels of p62. In addition, SH-
SY5Y cells were treated with Torin1, as a positive con-
trol to assess the beneficial effect of curcumin on
autophagy. Then, in order to investigate whether the
inhibition of GSK-3b mediated by curcumin contributes
to the induction of autophagy, we transfected SH-SY5Y
cells with scRNA or siGSK-3b, after 48 h transfection,
cells were treated with either curcumin or Torin1
(Figure 2(B)). Cells transfected with scRNA showed a
dramatic increase in LAMP1 mRNA and LC3-II protein
levels in the treatment of curcumin and torin1.
Interestingly, we observed siGSK-3b-transfected cells
without treatment could significantly increase the
Figure 1. Curcumin promotes TFEB nuclear translocation through the inhibition of GSK-3b activity in SH-SY5Y cells. (A) SH-SY5Y cells
were treated with curcumin in various concentrations (0, 2.5, 5, 10 and 20 mM) for 2h. The protein levels of p-GSK-3b, GSK-3b, p-b-cate-
nin, b-catenin, and b-actin were evaluated by western blot analysis. LiCl is used as positive control for the phosphorylation of GSK-3b.
(B) An immunofluorescence assay was performed to observe the nuclear translocation of TFEB. SH-SY5Y cells were transfected with
pEGFP-N1-TFEB for 48h, and then cells were treated with curcumin (10 mM and 20 mM) and Torin1 (5 mM) for 6h. Confocal microscopy
was utilised to detect localisation of TFEB (green) and nuclei (blue). Scale bar ¼ 10 mm. (C) The percentage of cells with nuclear TFEB.
(D) SH-SY5Y cells were transfected with pcDNA3.1, GSK3b CA, and GSK3b KD for 48h, followed by the administration of 20 mM curcumin
for 2h, and the protein level of TFEB was assessed in the nuclear and cytoplasmic fractions by western blot analysis (left panel). The
quantification of TFEB nucleus-cytoplasm ratios from these experiments is represented in the histogram (right panel). Data presented are
the means±SD (n¼ 3);  p< 0.001.
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Figure 2. Inhibition of GSK-3b by curcumin facilitates autophagy progression in SH-SY5Y cells. (A) SH-SY5Y cells were treated
with curcumin in a dose-dependent manner (0, 2.5, 5, 10, and 20 mM), and with Torin 1 (5 mM, 3 h) as a positive control. The
protein levels of LAMP1, LC3, p62, and a-tubulin were detected by western blot analysis (left panel). The quantification of
LAMP1/a-tubulin, LC3-II/a-tubulin, and p62/a-tubulin (right panel) from these experiments is represented. (B) SH-SY5Y cells trans-
fected with scramble siRNA (scRNA) and siRNA against GSK-3b (siGSK-3b) for 36 h, then cells were treated with curcumin and
torin 1. scRNA and siGSK-3b transfected cells were treated with curcumin (20 mM) and torin 1 (5 mM) for 24 h, and the mRNA
expression of LAMP1 was analysed by quantitative real time (qRT)-PCR. (C, D) SH-SY5Y cells were transfected with scRNA or
siGSK-3b for 36 h, and then cells were treated with curcumin (20 mM) for 24 h. (C) The transfected cells were treated with Torin 1
(5 mM) for 3 h. The protein levels of p-GSK-3b, GSK-3b, LC3 and a-tubulin were detected by western blot analysis (left panel). The
quantification of LC3-II to a-tubulin ratio from these experiments is represented in right panel. (D) The transfected cells were pre-
treated with CQ (5 mM) for 1 h. The protein levels of LC3 and a-tubulin were detected by western blot analysis (bottom panel).
The quantification of LC3-II to a-tubulin ratio from these experiments is represented in upper panel. (E) SH-SY5Y cells were co-
transfected with either scRNA or siGSK3b and mCherry-EGFP-LC3 and then treated with 20 mM curcumin for 24 h in presence or
absence of 10 mM chloroquine (CQ). The confocal images of SH-SY5Y cells showed yellow (autophagosomes) and red (autolyso-
somes) puncta. Scale bar represents 10 mm in all images. (F) SH-SY5Y cells transfected with pcDNA3.1, GSK-3b CA, and GSK-3b
KD of GSK-3b for 36 h. Then, cells were treated in the presence or absence of curcumin (20 mM) for 24 h. The protein level of
LC3 was determined by western blot. Data presented are mean ± SD;  p< 0.001 and NS: not significant.
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expression of LAMP1 and LC3-II compared to cells
transfected with scRNA, while curcumin and torin1
treatment showed no significant changes in LAMP1 and
LC3-II in both cells transfected with scRNA or siGSK-3b
(Figure 2(B,C)). To investigate the effect of curcumin on
the autophagy flux, we challenged the cells with
chloroquine (CQ), an inhibitor of autophagy flux. As
shown in Figure 2(D), CQ induced an increase in LC3-II
as it inhibits the autophagy flux. Although the LC3-II
levels were increased with curcumin treatment, the
combined treatment of curcumin and CQ showed a
much greater increase, indicating that curcumin did not
inhibit the autophagolysosomal maturation. The defi-
ciency of GSK-3b caused the increase of LC3-II levels,
compared with the control of scRNA-transfected cells,
but curcumin did not induce an increase in the levels of
LC3-II relative to the control in siGSK3b-transfected SH-
SY5Y cells. However, co-treatment with curcumin and
CQ or the treatment with CQ alone induced a higher
accumulation of LC3-II, compared with curcumin-
treated SH-SY5Y cells in the deficiency of GSK-3b. To
further monitor autophagy flux induced by curcumin, a
tandem fluorescent-tagged LC3 (GFP-mCherry-LC3)
expression plasmid was used. Consistent with Figure
2(D), curcumin increased autolysosomes (red puncta)
and co-treatment with curcumin and CQ showed the
increase of autophagosomes (yellow puncta) by inhibit-
ing autophagy flux in presence of GSK3b (Figure 2(E)).
Taken together, we could conclude that curcumin
increases autophagy via GSK-3b inhibition. Next, to con-
firm the activity of GSK-3b on autophagy, we trans-
fected cells with GSK-3b CA or KD mutants, and found
that the increase of LC3-II by curcumin treatment was
significantly decreased in GSK-3b CA-transfected SH-
SY5Y cells. However, in cells transfected with GSK-3b
KD, the level of LC3-II was dramatically elevated in both
the presence and absence of curcumin administration
(Figure 2(F)). All of these results demonstrated that the
induction of autophagy by curcumin is mainly associ-
ated with the inhibition of GSK-3b.
Oxidative stress induced by H2O2 is mitigated by
inhibition of GSK-3b
Curcumin has received increased interest due to its
unique interaction with inflammatory and antioxidant
pathways, as well as amyloid aggregation [41]. In add-
ition, the phosphorylation of GSK-3b (S9) has been
shown to exert anti-oxidant effects through promoting
nuclear accumulation of Nrf2 and the expression of
anti-oxidant genes [42]. To determine whether the anti-
oxidant effect of curcumin is mediated by the inhibition
of GSK-3b in SH-SY5Y cells, we first explored the phos-
phorylation of GSK-3b (S9) by curcumin in the presence
of H2O2. According to our western blot results, cells co-
treated with H2O2 and curcumin showed a significant
increase in p-GSK-3b (S9) (Figure 3(A)), suggesting that
curcumin could inhibit GSK-3b activation under oxida-
tive stress conditions. Several studies have indicated
that curcumin could increase the antioxidant gene, HO-
1, expression through the promotion of Nrf2 nuclear
translocation. Activation of the mouse Hmox-1 gene
promoter by curcumin is mediated by antioxidant-
responsive elements (AREs) [43]. To investigate whether
curcumin could enhance ARE promoter activity through
the inhibition of GSK-3b, we next performed a luciferase
assay, and found that cells co-treated with H2O2 and
curcumin showed a robust increase in ARE luciferase
activity compared to the cells treated with H2O2 alone
(Figure 3(B)). Interestingly, we also observed that LiCl
could significantly increase ARE promoter activity in the
presence or absence of H2O2 (Figure 3(B)), suggesting
that the inhibition of GSK-3b can enhance ARE pro-
moter activity. Next, to detect whether curcumin could
elevate the expression of anti-oxidant genes, we ana-
lysed HO-1 mRNA expression. Curcumin dramatically
increased the mRNA level of HO-1 in the presence or
absence of H2O2 (Figure 3(C)). ARE promoter activity
has been reported to increase the anti-oxidant response
and reduce ROS levels [29]. Therefore, we performed
flow cytometry analysis to detect the production of
ROS in SH-SY5Y cells transfected with scRNA or siGSK-
3b. Treatment with curcumin or LiCl significantly
decreased ROS levels in the presence of H2O2.
Additionally, we also observed that cells transfected
with siGSK-3b could significantly diminish the produc-
tion of ROS under H2O2 treatment compared to cells
transfected with scRNA (Figure 3(D)). Taken together,
these results demonstrated that the anti-oxidant effect
of curcumin requires the activation of the Nrf2/ARE
pathway and induction of HO-1 through the inhibition
of GSK-3b.
GSK-3b inhibition by curcumin degrades
aggregated APP through autophagy in SH-
SY5Y cells
APP is a key protein in the pathogenesis of AD.
Autophagy is reported as a critical feature necessary for
the clearance of aggregated amyloid-b protein [44].
According to our results (Figures 2 and 3), we showed
that curcumin promoted autophagy and exerted anti-
oxidant effects on H2O2-mediated oxidative stress.
Therefore, to investigate whether curcumin could
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inhibit the aggregation of APP through the induction of
autophagy, SH-SY5Y cells were transfected with human
FL-APP-WT and a mutant form of APP (APP-Swe/Ind) for
48 h, prior to treatment with curcumin for 24 h. First of
all, we evaluated the effect of curcumin on cell viability
in WT or mutant of APP-transfected cells. As shown in
Supplementary Figure S2(A), curcumin did not affect
cell viability. Immunofluorescence results showed that
the accumulation of APP was dramatically decreased in
the curcumin-treated SH-SY5Y cells (Figure 4(A)).
Moreover, curcumin treatment decreased the levels of
FL-APP, while the levels of LC3-II significantly increased
(Figure 4(B)). These data supported that curcumin could
inhibit the aggregation of APP in neuronal cells. In
order to explore whether the inhibition of APP aggrega-
tion by curcumin was linked to GSK-3b inactivation, SH-
SY5Y cells were transfected with CA and KD mutant
forms of GSK-3b for 48 h, prior to treatment with 20mM
curcumin for 24 h. Our results revealed that curcumin
significantly increased the mRNA expression of several
lysosomal markers, including that of LAMP1 and
MCOLN1. However, in cells transfected with the CA-
Figure 3. Oxidative stress induced by H2O2 is mitigated by inhibition of GSK-3b in SH-SY5Y cells. (A) SH-SY5Y cells were pre-treated
with curcumin (10 mM and 20 mM) and LiCl (20mM) for 2 h, and then cells were changed into fresh medium followed by the admin-
istration of H2O2 (200 mM) for 48 h. The expression of p-GSK-3b and GSK-3b was evaluated by western blot analysis. (B) SH-SY5Y
cells were pre-treated with curcumin (20 mM) and LiCl (20mM) for 30min followed by the treatment of H2O2 (200 mM) for 6 h,
before being co-transfected with a pCignal Lenti-ARE reporter and pCignal Lenti-TK-Renilla. After treatment with curcumin, lucifer-
ase activity was analysed. The expression levels obtained from pCignal Lenti-ARE reporter-transduced cells without 4-PG treatment
were normalised to 1. (C) SH-SY5Y cells were pre-treated with curcumin (20 mM) for 30min followed by stimulation with H2O2 (200
mM) for 6 h; HO-1 mRNA levels were detected by qRT-PCR. (D) SH-SY5Y cells were transfected with scRNA and human GSK-3b
siRNA. After 20 h incubation, cells were treated with curcumin (20 mM) and LiCl (20mM) before being incubated in, fresh medium
treated with H2O2 (200 mM) for 48 h; after incubation the production of intracellular ROS was detected by staining with DCF-DA and
examining with a fluorescence-activated cell sorter (FACS Canto II). The fold change of fluorescence mean intensity is presented as
mean ± SD (n¼ 3). Data presented are the mean ± SD (n¼ 3); p< 0.05, p< 0.01, and  p< 0.001.
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GSK-3b mutant, the beneficial effect of curcumin on
LAMP1 and MCOLN1 expression was abolished, and
was dramatically decreased compared to cells trans-
fected with pcDNA. These lysosomal biomarkers were
significantly increased in KD-GSK-3b transfected cells
(Figure 4(C,D)). These data suggested that GSK-3b
inhibition plays a critical role in curcumin-mediated
autophagy. Furthermore, we investigated whether cur-
cumin could decrease the expression of APP due to the
induction of autophagy; the levels of APP were remark-
ably decreased by curcumin treatment in cells trans-
fected with pcDNA (Figure 4(E)), and significantly
increased in CA-GSK-3b-transfected cells treated with or
without curcumin. Conversely, we found that the levels
of LC3-II were decreased compared to the cells trans-
fected with pcDNA. In KD-GSK-3b transfected cells, APP
expression was significantly decreased, while LC3-II lev-
els were enhanced (Figure 4(E)). To confirm the
Figure 4. Curcumin-induced GSK-3b inhibition degrades aggregated APP through autophagy in SH-SY5Y cells. (A) SH-SY5Y cells
transfected with a wild type full length-APP (FL-APP WT) and a mutant form of APP (APP-Swe/Ind) for 36h. Then, cells were
treated with curcumin (20 mM) for 24 h. Immunofluorescence was performed to detect the FL-APP (red). Scale bars represent 10
mm in all images. (B) SH-SY5Y cells were transfected with a APP-Swe/Ind for 36 h, and then cells were treated with curcumin at
different concentrations (0, 2.5, 5, 10, and 20 mM) for 24 h and LiCl (20mM) for 12 h. The protein levels of FL-APP and LC3 were
determined by western blot analysis. (C-E) SH-SY5Y cells were transfected with pcDNA3.1, GSK3b CA, and GSK3b KD for 36 h, and
then treated with 20 mM curcumin for 24 h. The mRNA levels of LAMP1 (C) and MCOLN1 (D) were measured by qRT-PCR. (E) The
protein level of FL-APP and LC3 were analysed by western blot (left panel). The quantification of FL-APP/a-tubulin (middle panel)
and LC3-II/a-tubulin (right panel) from these experiments is represented. (F) SH-SY5Y cells were transfected with a APP-Swe/Ind
for 36 h, and then cells were treated with curcumin (20 mM) for 24 h and Bafilomycin (100 nM) for 3 h. The protein levels of FL-
APP and a-tubulin were determined by western blot analysis. Data represented are the means ± SD of three independent experi-
ments. p< 0.05, p< 0.01, and  p< 0.001. NS: not significant.
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clearance of APP through lysosome activation, APP-
Swe/Ind-transfected SH-SY5Y cells were treated with
Bafilomycin A, a lysosome inhibitor. The decrease of
APP levels with curcumin was reversed by Bafilomycin
A treatment (Figure 4(F)). All these data suggested that
autophagy induced by curcumin could promote the
clearance of APP, which is determined by the inactiva-
tion of GSK-3b.
Activation of autophagy by curcumin reduces
a-syn accumulation through inhibition of GSK-3b
in SH-SY5Y cells
Here, to determine whether curcumin could decrease
other aggregative proteins, namely a-syn, through pro-
motion of autophagy and inhibition of GSK-3b, SH-SY5Y
cells were first transfected with mutant form of a-syn
(A53T) to construct an in vitro PD model, and were then
treated with thapsigargin (Tg, 200 nM) for 1 h, which is
a GSK-3b activator [45,46]. Our results showed that cur-
cumin has no effect on cell viability (Supplementary
Figure S2(B)), increases the levels of LC3-II and reduces
the accumulation of a-syn, while Tg treatment signifi-
cantly attenuates the levels of LC3-II and reversibly
increases the levels of a-syn (Figure 5(A)). Tg has differ-
ent effects depending on incubation times. At short
incubation time (30min), Tg inhibited Ca2þ-ATPase [19].
Up to 3 h treatment with Tg did not affect mTOR activ-
ity [19], but it suppressed mTOR activity for 24 h incuba-
tion [47]. Previous studies reported Tg treatment for 1 h
activated GSK-3b [48]. Thus, in this study, we postulated
that Tg treatment for 1 h may be responsible for GSK-
3b activation without the effects of Tg on Ca2þ-ATPases
inhibitor and mTOR activity. To further confirm the
Figure 5. Activation of autophagy by curcumin reduces a-syn accumulation through inhibition of GSK-3b in SH-SY5Y cells. (A)
SH-SY5Y cells were transfected with a human a-syn mutant (A53T) for 48 h, and then cells were treated with or without 200nM
thapsigargin for 1h. The protein levels of a-syn and LC3 were assessed by western blot analysis. (B) SH-SY5Y cells were trans-
fected with pEGFP-LC3 and a human a-syn mutant for 36 h. Then, cells were treated with curcumin (20 mM) or LiCl (20mM) for
24 h. Immunofluorescence was performed to detect the co-localisation of LC3 (green) vesicles and a-syn (red) (right panel). The
percentage of cells with co-localisation of LC3 and a-syn (left panel). (C) SH-SY5Y cells were transfected with pcDNA3.1, GSK3b
CA, and GSK3b KD for 36 h, and then cells were treated with or without 20 mM curcumin for 24 h. The protein levels of a-syn,
LC3 and a-tubulin were detected by western blot analysis (left panel). The quantification of a-syn/a-tubulin (middle panel) and
LC3-II/a-tubulin (right panel) from these experiments is represented. (D) SH-SY5Y cells were transfected with a human a-syn
mutant (A53T) for 48 h, and then cells were treated with curcumin (20 mM) for 24 h and Bafilomycin (100 nM) for 3 h. The protein
levels of a-syn and a-tubulin were assessed by western blot analysis. Data represented are the means ± SD of three independent
experiments. p< 0.01, and  p< 0.001. NS: not significant.
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mechanism of curcumin-mediated down-regulation of
a-syn, SH-SY5Y cells were co-transfected with LC3-GFP
and a-syn and treated with curcumin or LiCl. The treat-
ment of curcumin or LiCl significantly increased the per-
centage of LC3 vesicles containing a-syn (Figure 5(B)).
In this study, our results demonstrated that curcumin
facilitates autophagy progression, which is associated
with the inactivation of GSK-3b (Figure 2). Next, to con-
firm whether the activity of GSK-3b is linked to the deg-
radation of a-syn through the induction of autophagy,
we transfected cells with CA or KD mutants. Cells trans-
fected with GSK-3b CA or KD showed an opposite
induction of the expression of a-syn and the level of
LC3-II, indicating that GSK-3b exhibits a critical role in
the a-syn degradation through the enhancement of
autophagy (Figure 5(C)). We confirmed whether curcu-
min promotes the clearance of a-syn through the acti-
vation of the lysosome. As shown in Figure 5(D),
Bafilomycin A reversed the levels of a-syn decreased by
curcumin. To Thus, these results demonstrated that cur-
cumin-induced GSK-3b inhibition is required for the
removal of aggregated protein by autophagy.
Discussion
Our data demonstrated, for the first time, that the regu-
lation of curcumin on autophagy in human neuroblast-
oma cells is dependent on the inactivation of GSK-3b
and the nuclear translocation of TFEB. As curcumin
activity leads to an increase in autophagy through GSK-
3b inhibition, we suggest that curcumin attenuates
amyloidogenesis in human neuroblastoma cells.
Curcumin by the binding pocket of GSK-3b potently
inhibits its activity [49]. GSK-3b activity is regulated by
two different sites of phosphorylation, Tyr216 and Ser9
[37]; upon phosphorylation of Ser9, the activity of GSK-
3b is inhibited, which will subsequently relieve autoph-
agy inhibition. Inactivation of GSK-3b has been reported
to be involved in the protective effect of curcumin
against oxidative stress [50,51]. The main targets of
autophagy are intracellular damaged or aging organ-
elles, misfolded proteins, and excessive biological mac-
romolecules [52]. Consistent with other studies, we
observed that the inhibition of GSK-3b by both LiCl and
curcumin could elevate the process of autophagy and
protect cells from H2O2-induced oxidative stress. A pre-
vious study showed that the phosphorylation of differ-
ent serine residues in TFEB could control its nuclear-
cytoplasmic shuttling [53]. As shown in Figure 1(D),
continuous nuclear accumulation of TFEB can be
observed in cells transfected with the GSK-3b KD
mutant plasmid, even without the treatment of
curcumin. Soluble LC3-I can be converted into LC3-II,
which is involved in the formation of autophagosomes
[54]. The autophagy-related involvement of LC3 and
LAMP1 are the main reason why these proteins were
selected as markers to explore the effect of GSK-3b
inhibition on autophagy. In addition, curcumin inhib-
ited mTORC1 activity [55]. In human neuroblastoma
cells, we suggested that curcumin has the possibility to
enhance the TFEB activity by decreasing mTORC1 activ-
ity (Supplementary Figure 1S (D,E)). Oxidative stress
plays a critical role in various neurodegenerative dis-
eases, thus alleviation of oxidative stress is a potential
strategy for therapeutic intervention and/or prevention
of these diseases [56]. It has been found that curcumin
confers protection against oxidative stress induced by
H2O2 [12]. The Nrf2/HO-1 pathway plays a crucial role in
protecting against oxidative stress. GSK-3b may be
linked to regulating Nrf2 in a Kelch-like ECH-associated
protein 1 (Keap1)-in dependent manner [57–59].
Multiple studies have shown that curcumin exhibits
numerous biological activities, including the ability to
induce the expression of Nrf2/HO-1, anti-oxidant
enzymes, and ARE pathways [11,60,61]. Additionally,
inhibition of GSK-3b by LiCl upregulates the Nrf2/HO-1
pathway by enhancing Nrf2-ARE binding activity, and
increasing HO-1 expression [62]. Consistent with these
reports, our results suggested that ARE promoter activ-
ity, assessed by luciferase assay, was significantly
enhanced by the administration of curcumin. Thus, we
propose that the protective effect of curcumin against
oxidative stress might be due to the upregulation of
the Nrf2/HO-1 pathway through the phosphorylation of
S9-GSK-3b. Next, to evaluate the relationship between
GSK-3b activity and autophagy induced by curcumin in
the neuron, SH-SY5Y cells were transfected with mutant
FL-APP and a-syn, which are considered important risk
factors in AD and PD, respectively. Curcumin-induced
autophagy can effectively increase the clearance of
these aggregated proteins in SH-SY5Y cells. To confirm
these cellular mechanisms of curcumin on the neuron,
we need to further study using primary neuronal cells
because SH-SY5Y cells have cancerous properties that
differ greatly from normal neuronal features [63].
In summary, our data revealed that curcumin can
increase the nuclear translocation of TFEB to promote
the process of autophagy, and exert an anti-oxidant
effect through the activation of ARE promoter activity
and HO-1 expression. All of these beneficial effects of
curcumin are associated with the inhibition of GSK-3b
through the phosphorylation of the serine 9 residue.
These finding may unveil new strategies for pharmaco-
logical intervention in neurodegenerative disorders.
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